Quipt Home Medical (QIPT) CCO fully cashed out in go-private deal

Rhea-AI Filing Summary

Quipt Home Medical Corp. Chief Compliance Officer Miles Mark Alan reported dispositions of both common shares and stock options tied to the company’s go‑private transaction. On March 16, 2026, he disposed of 110,000 common shares at US$3.65 per share to the acquiring purchasers under a plan of arrangement.

He also disposed of 57,500 stock options, with exercise prices of US$1.11, US$6.27, and US$6.14, which were treated in cash in line with the arrangement terms. Following these transactions, the filing shows he holds no remaining Quipt common shares or stock options.

Insights

Equity compensation and M&A analyst

Executive’s equity is cashed out as part of Quipt’s change of control, leaving no reported remaining stake.

The filing shows Miles Mark Alan, Chief Compliance Officer of Quipt Home Medical Corp., disposing of 110,000 common shares at US$3.65 per share in connection with the company’s acquisition via a court‑approved plan of arrangement under the British Columbia statute.

In addition, 57,500 stock options with exercise prices of US$1.11, US$6.27, and US$6.14 were surrendered under the same agreement, with in‑the‑money options receiving cash equal to the spread and out‑of‑the‑money options cancelled. After these steps, the report shows no remaining Quipt equity or options held by this executive.

This is a mechanistic clean‑up of equity awards and shares triggered by the change of control, not an open‑market sale, so it is best viewed as part of the broader transaction economics rather than a standalone signal about the executive’s view of the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miles Mark Alan

(Last) (First) (Middle)

C/O QUIPT HOME MEDICAL CORP.

1019 TOWN DRIVE

(Street)

WILDER KY 41076

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Quipt Home Medical Corp. [ QIPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Compliance Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/16/2026(1)		D		110,000(2)	D	$3.65	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.11	03/16/2026		D			12,500	(3)	(3)	Common Shares	12,500	(3)	0	D
Stock Option (Right to Buy)	$6.27	03/16/2026		D			30,000	(3)	(3)	Common Shares	30,000	(3)	0	D
Stock Option (Right to Buy)	$6.14	03/16/2026		D			15,000	(3)	(3)	Common Shares	15,000	(3)	0	D

Explanation of Responses:

1. On March 16, 2026, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware limited liability company (individually, "REM Aggregator", and collectively with B.C. Purchaser ("Purchaser" or "Purchasers") acquired all of the issued and outstanding common shares (the "Shares") of Issuer under a plan of arrangement (the "Arrangement Agreement") pursuant to the Business Corporations Act (British Columbia) (the "BCBCA"). At the Effective Time (the "Effective Time") of the Arrangement Agreement each Share, other than any Shares held by shareholders who may properly exercised dissent rights under the BCBCA ("Dissenting Shareholders"), were deemed to be transferred to Purchaser in consideration for the right to receive a cash payment from the Purchaser in the amount equal to US$3.65, without interest.

2. The Shares include restricted share units ("RSUs"), which RSUs outstanding immediately prior to the Effective Time (whether vested or unvested) were, without any further action by or on behalf of the holder of any such RSU, deemed to be transferred by such holder to Issuer in consideration for the right to receive a cash payment from Issuer in the amount equal to US$3.65, less any amounts Issuer is required to withhold for taxes, without interest. Each RSU is the economic equivalent of one Share.

3. Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option exercisable to acquire one or more Shares from the Issuer (an "Option"), outstanding immediately prior to the Effective Time (whether vested or unvested) were deemed to be unconditionally vested and exercisable and will, without any further action by or on behalf of a holder of the Option, deemed to be surrendered and transferred by such holder to the Issuer in consideration for the right to receive a cash payment from the Issuer in an amount equal to the excess, if any, of US$3.65 over the exercise price of such option, less any amounts the Issuer is required to withhold for taxes, without interest. Any option for which the exercise price is equal to or greater than US$3.65 will be cancelled for no consideration.

	/s/ Mark Alan Miles	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Quipt Home Medical (QIPT) executive Miles Mark Alan report in this Form 4?

He reported disposing of 110,000 Quipt common shares at US$3.65 per share and surrendering 57,500 stock options. These transactions occurred as part of Quipt’s acquisition under a plan of arrangement, rather than through open‑market trading.

At what price were Quipt Home Medical (QIPT) shares cashed out for Miles Mark Alan?

Each common share was exchanged for US$3.65 in cash. This price came from the plan of arrangement under which all issued and outstanding Quipt common shares, other than properly dissenting shares, were transferred to the purchasers at that fixed cash consideration.

How were Miles Mark Alan’s Quipt (QIPT) stock options treated in the acquisition?

All outstanding options were deemed vested, then surrendered for cash equal to US$3.65 minus their exercise price, less taxes. Options with exercise prices at or above US$3.65 were cancelled for no consideration under the arrangement terms.

How many Quipt Home Medical (QIPT) stock options did Miles Mark Alan dispose of?

He disposed of 57,500 stock options in total: 12,500 options at an exercise price of US$1.11, 30,000 options at US$6.27, and 15,000 options at US$6.14, all processed under the acquisition agreement.

Does Miles Mark Alan hold any Quipt Home Medical (QIPT) shares or options after these transactions?

According to the Form 4, his direct holdings fall to zero common shares and no remaining stock options following the cash‑out of shares and the surrender or cancellation of options completed at the effective time of the arrangement.

What happened to Quipt Home Medical (QIPT) restricted share units in this transaction context?

Footnotes explain that outstanding restricted share units were transferred to the issuer for a cash payment of US$3.65 per unit, less taxes. Each restricted share unit was treated as the economic equivalent of one common share under the arrangement.